Evidence map›Paper›PMID 37185821›Full record

ArticleThe Journal of pathology2023

IFN-γ and androgens disrupt mitochondrial function in murine myocytes.

John M Fenimore, Danielle A Springer, Maria E Romero, Elijah F Edmondson, Dan W McVicar, Sudhirkumar Yanpallewar, Michael Sanford, Thea Spindel, Elizabeth Engle, Thomas J Meyer and 2 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

John M FenimoreCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0002-6848-9274
Danielle A SpringerMurine Phenotyping Core, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
Maria E RomeroCVPath Institute, Gaithersburg, MD, USA.
Elijah F EdmondsonPathology and Histology Lab, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0002-6106-3705
Dan W McVicarCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0002-1112-5111
Sudhirkumar YanpallewarMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0001-5929-4822
Michael SanfordCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0002-9411-2606
Thea SpindelCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Elizabeth EngleCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Thomas J MeyerCCR Collaborative Bioinformatics Resource (CCBR), Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0002-7185-5597
Julio C ValenciaCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0003-0077-8640
Howard A YoungCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0002-3118-5111
Frederick National Laboratory for Cancer Research · USHospital Militar Principal · PTCVPath Institute · USNational Cancer Institute · USNational Heart Lung and Blood Institute · US

Funding

Control of Cytokine Gene Expression in LymphoidMyeloid CellsZIABC009283 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI YOUNG, HOWARD · 2009 to 2024
$22.7M
EXPAND PARTICIPATION BY MINORITIES IN BIOMEDICAL SCIENCER25GM055036 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI SUMMERS, MICHAEL FINLEY · 1996 to 2021
$16.9M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS Z99 CA999999Intramural NIH HHS ZIA BC009283NCI NIH HHS HHSN261200800001ENIGMS NIH HHS R25 GM055036
6 · The paper itself

Abstract

The effect of cytokines on non-traditional immunological targets under conditions of chronic inflammation is an ongoing subject of study. Fatigue is a symptom often associated with autoimmune diseases. Chronic inflammatory response and activated cell-mediated immunity are associated with cardiovascular myopathies which can be driven by muscle weakness and fatigue. Thus, we hypothesize that immune dysfunction-driven changes in myocyte mitochondria may play a critical role in fatigue-related pathogenesis. We show that persistent low-level expression of IFN-γ in designated IFN-γ AU-Rich Element deletion mice (ARE mice) under androgen exposure resulted in mitochondrial and metabolic deficiencies in myocytes from male or castrated ARE mice. Most notably, echocardiography unveiled that low ejection fraction in the left ventricle post-stress correlated with mitochondrial deficiencies, explaining how heart function decreases under stress. We report that inefficiencies and structural changes in mitochondria, with changes to expression of mitochondrial genes, are linked to male-biased fatigue and acute cardiomyopathy under stress. Our work highlights how male androgen hormone backgrounds and active autoimmunity reduce mitochondrial function and the ability to cope with stress and how pharmacological blockade of stress signal protects heart function. These studies provide new insight into the diverse actions of IFN-γ in fatigue, energy metabolism, and autoimmunity. © 2023 The Pathological Society of Great Britain and Ireland. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

Indexed as

AndrogensInterferon-gammaAnimalsCytokinesInflammationMaleMiceMitochondriaMuscle CellsAndrogensCytokinesIFNG protein, mouseInterferon-gammaautoimmune diseasecardiomyopathyIFN-γinflammationmitochondriasystemic lupus erythematosus (SLE)

Identifiers

PMID37185821
PMCPMC10330777
OpenAlexW4367321874

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.